Dali Life Science Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 2 Year, 3 Months
- Open Charges ₹ 5.00 M
About Dali Life Science
Dali Life Science Private Limited (DLSPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 11 October 2022 (Two years and three months 28 days old ). Its registered office is in Coimbatore, Tamil Nadu, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹5.00 M.
Jansi Andavan and Dali Raman serve as directors at the Company.
Company Details
-
Location
Coimbatore, Tamil Nadu, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85300TZ2022PTC040094
-
Company No.
040094
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
11 Oct 2022
-
Date of AGM
-
-
Date of Balance Sheet
-
-
Listing Status
Unlisted
-
ROC Code
Roc Coimbatore
Industry
Who are the key members and board of directors at Dali Life Science?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jansi Andavan
|
Director | 11-Oct-2022 | Current |
|
Dali Raman
|
Director | 11-Oct-2022 | Current |
Financial Performance of Dali Life Science.
Enhance accessibility to Dali Life Science's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Dali Life Science?
Unlock access to Dali Life Science's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Aaric Enterprises Private LimitedJansi Andavan and Dali Raman are mutual person
-
Daludad Creations Private Limited
Jansi Andavan and Dali Raman are mutual person
-
Icare Poly Clinics Private Limited
Jansi Andavan and Dali Raman are mutual person
-
Silia Foods Private Limited
Dali Raman is a mutual person
Charges (Loans)
₹5.00 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 30 Mar 2023 | State Bank Of India | ₹5.00 M | Open |
How Many Employees Work at Dali Life Science?
Unlock and access historical data on people associated with Dali Life Science, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dali Life Science, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dali Life Science's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.